Enhancing Bioavailability and Stability of Curcumin Using Solid Lipid Nanoparticles (CLEN): A Covenant for Its...

Area of Science:

• Nanomedicine
• Drug Delivery Systems
• Cancer Therapeutics

Background:

• Curcumin exhibits potent anti-inflammatory, antioxidant, and antitumor properties, crucial for chemotherapy.
• Poor aqueous solubility, rapid metabolism, and systemic elimination limit curcumin's therapeutic efficacy.
• Nanotechnology offers solutions to overcome the biopharmaceutical challenges of poorly soluble drugs like curcumin.

Purpose of the Study:

• To develop and characterize curcumin encapsulated lipidic nanoconstructs (CLEN) for improved therapeutic potential.
• To enhance curcumin's solubility, bioavailability, and stability using solid lipid nanoparticles (SLNs).
• To evaluate the controlled release and enhanced stability of the CLEN formulation.

Main Methods:

• Curcumin was encapsulated into solid lipid nanoparticles (SLNs) to create CLEN.
• Solubility, drug loading, and release kinetics (zero-order vs. first-order) were assessed.
• Oral bioavailability and formulation stability across different pH values were determined.

Main Results:

• CLEN achieved a 1.4 × 10^6-fold increase in curcumin's aqueous solubility and 15% drug loading.
• CLEN demonstrated zero-order release kinetics, indicating controlled drug release.
• Oral bioavailability was 69.78 times higher than free curcumin and 9.00 times higher than CurcuWIN®.
• Enhanced stability was observed at pH 6.8 (104x), 1.2 (13.3x), and 7.4 (10x).

Conclusions:

• CLEN formulation significantly overcomes curcumin's bioavailability and stability limitations.
• The developed nanoconstructs offer a promising platform for effective cancer and inflammatory disease treatment.
• CLEN represents a significant advancement in leveraging curcumin's therapeutic potential through nanotechnology.